Bambec (bambuterol) is an oral long-acting beta₂-agonist for once-daily treatment of the symptoms of asthma, particularly in patients who are unable to use inhaled products (such as children and the elderly). It is supplied as tablets and as a liquid medicine.

Bambec is a pro-drug that it is slowly converted in the body to the active form, thus providing a prolonged action.

Bambec is not intended to treat acute asthma attacks.